Delivery Order SPE2DB24D2101-SPE2DB25FKKBY

Award Date 5/1/25
Potential Completion Date 5/2/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $2,018.28 firm fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of VALTOCO 10 MG NASAL SPRAYS, a critical care medication, with an ultimate completion date of August 22, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical to provide a...
This federal contract award, valued at $1,146.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,108,098 units of VALTOCO 10 MG NASAL SPRAYS, with a completion date of May 2, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $3,558.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VALTOCO 10 MG nasal sprays, with a completion date of November 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical, which...
This federal contract award, with ID SPE2DB22D1041|SPE2DB25FTYA1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,394.78 delivery order is for the supply of VALTOCO 10 MG NASAL SPRAYS, a pharmaceutical product. The contract is a Firm Fixed Price (FFP) type, with an ultimate completion date of October 24, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of VALTOCO 15 MG nasal sprays. The $2,124.34 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for AmerisourceBergen to provide a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,828.60, is for the delivery of VALTOCO 10 MG NASAL SPRAYS. It is a Firm Fixed Price Delivery Order contract with a performance period ending on March 24, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds an Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the delivery of pharmaceutical products, specifically VALTOCO 10 MG nasal sprays. The contract has a ceiling value of $1,672.48 and is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor on this award, which...
This federal contract award, valued at $2,657.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALTOCO 10 MG NASAL SPRAYS, a medical product, with a performance period through March 18, 2025. The contract was awarded as a Firm Fixed Price Delivery Order, and there was no set-aside designation used. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $1,850.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,077,530 units of the nasal spray medication VALTOCO 10 MG. The contract has a firm fixed price and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a...
This federal contract award, valued at $3,232.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALTOCO 10 MG NASAL SPRAYS, a specialized pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of July 17, 2024. It is not associated with a set-aside designation, indicating open...
  • SPE2DB24D2101
    Indefinite Delivery Contract
  • SPE2DB24D2101-SPE2DB25FKKBY
    Delivery Order

This federal contract award, valued at $1,129.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VALTOCO 10 MG NASAL SPRAYS, a pharmaceutical product, with a performance period ending on May 2, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is not set-aside and allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 8/3/25, 1:31 AM